Natural Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Review

被引：4

作者：

Singh, Sonia ^{[1
]}

Sharma, Himanshu ^{[2
]}

Ramankutty, Raghavan ^{[3
]}

Ramaswamy, Sarada ^{[3
]}

Agrawal, Nitin ^{[4
]}

机构：

[1] GLA Univ, Inst Pharmaceut Res, Mathura 281406, Uttar Pradesh, India

[2] GLA Univ, Dept Comp Engn & Applicat, Mathura 281406, Uttar Pradesh, India

[3] Datha Ayuryoga Int Hlth Inst, DOO, Podgorica, Montenegro

[4] Raja Balwant Singh Engn Tech Campus, Fac Pharm, Agra 283105, Uttar Pradesh, India

来源：

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING | 2023年 / 26卷 / 15期

关键词：

PCSK9; LDL; cholesterol; inhibitors; monoclonal antibodies; ER; DENSITY-LIPOPROTEIN RECEPTOR; LUPIN PROTEIN; PCSK9; EXPRESSION; GREEN TEA; EPIGALLOCATECHIN GALLATE; INSULIN-RESISTANCE; GENE-EXPRESSION; BERBERINE; CHOLESTEROL; PHARMACOKINETICS;

D O I：

10.2174/1386207326666230627122630

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

PCSK9 (proprotein convertase subtilisin/kexin type 9) is an enzyme that helps to reduce cardiovascular events. This clinical result is attributable primarily to the crucial involvement of PCSK9 in regulating the low-density lipoprotein cholesterol level. Because oral anti-PCSK9 medications have yet to be available, the benefits of this unique treatment approach have been diminished. Identifying naturally occurring PCSK9 inhibitors may lead to considerable progress in this regard. These inhibitors serve as a starting point for producing oral and effective components that could be used with statins to boost the proportion of patients who achieve their LDL-cholesterol goals. In this review, we have briefly summarised the recent information regarding natural components or extracts that have been shown to inhibit PCSK9 activity.

引用

页码：2668 / 2678

页数：11

共 107 条

[1] The medicinal plant goldenseal is a natural LDL-lowering agent with multiple bioactive components and new action mechanisms [J].

Abidi, Parveen ;

Chen, Wei ;

Kraemer, Fredric B. ;

Li, Hai ;

Liu, Jingwen .

JOURNAL OF LIPID RESEARCH, 2006, 47 (10) :2134-2147

[2] Mutations in PCSK9 cause autosomal dominant hypercholesterolemia [J].

Abifadel, M ;

Varret, M ;

Rabès, JP ;

Allard, D ;

Ouguerram, K ;

Devillers, M ;

Cruaud, C ;

Benjannet, S ;

Wickham, L ;

Erlich, D ;

Derré, A ;

Villéger, L ;

Farnier, M ;

Beucler, I ;

Bruckert, E ;

Chambaz, J ;

Chanu, B ;

Lecerf, JM ;

Luc, G ;

Moulin, P ;

Weissenbach, J ;

Prat, A ;

Krempf, M ;

Junien, C ;

Seidah, NG ;

Boileau, C .

NATURE GENETICS, 2003, 34 (02) :154-156

[3] Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages [J].

Adorni, Maria Pia ;

Cipollari, Eleonora ;

Favari, Elda ;

Zanotti, Ilaria ;

Zimetti, Francesca ;

Corsini, Alberto ;

Ricci, Chiara ;

Bernini, Franco ;

Ferri, Nicola .

ATHEROSCLEROSIS, 2017, 256 :1-6

[4] Evaluation of Antimicrobial Activity and Cytotoxicity Effects of Extracts of Piper nigrum L. and Piperine [J].

Alves, Fabrine Silva ;

Cruz, Jorddy Neves ;

Ramos, Ingryd Nayara de Farias ;

Brandao, Dayse Lucia do Nascimento ;

Queiroz, Rafael Nascimento ;

da Silva, Glauce Vasconcelos ;

da Silva, Gleice Vasconcelos ;

Dolabela, Maria Fani ;

da Costa, Marcondes Lima ;

Khayat, Andre Salim ;

do Rego, Jose de Arimateia Rodrigues ;

Brasil, Davi do Socorro Barros .

SEPARATIONS, 2023, 10 (01)

[5] Habitat-Dependent Variations in Berberine Content of Berberis asiatica ROXB. ex. DC. in Kumaon, Western Himalaya [J].

Andola, Harish Chandra ;

Gaira, Kailash Singh ;

Rawal, Ranbeer Singh ;

Rawat, Mohan Singh Muniyari ;

Bhatt, Indra Dutt .

CHEMISTRY & BIODIVERSITY, 2010, 7 (02) :415-420

[6] Consuming a mixed diet enriched with lupin protein beneficially affects plasma lipids in hypercholesterolemic subjects: A randomized controlled trial [J].

Baehr, Melanie ;

Fechner, Anita ;

Kiehntopf, Michael ;

Jahreis, Gerhard .

CLINICAL NUTRITION, 2015, 34 (01) :7-14

[7] Lupin protein positively affects plasma LDL cholesterol and LDL:HDL cholesterol ratio in hypercholesterolemic adults after four weeks of supplementation: a randomized, controlled crossover study [J].

Baehr, Melanie ;

Fechner, Anita ;

Kraemer, Julia ;

Kiehntopf, Michael ;

Jahreis, Gerhard .

NUTRITION JOURNAL, 2013, 12

[8] The Role of Nutraceuticals in Statin Intolerant Patients [J].

Banach, Maciej ;

Patti, Angelo Maria ;

Giglio, Rosaria Vincenza ;

Cicero, Arrigo F. G. ;

Atanasov, Atanas G. ;

Bajraktari, Gani ;

Bruckert, Eric ;

Descamps, Olivier ;

Djuric, Dragan M. ;

Ezhov, Marat ;

Fras, Zlatko ;

von Haehling, Stephan ;

Katsiki, Niki ;

Langlois, Michel ;

Latkovskis, Gustavs ;

Mancini, G. B. John ;

Mikhailidis, Dimitri P. ;

Mitchenko, Olena ;

Moriarty, Patrick M. ;

Muntner, Paul ;

Nikolic, Dragana ;

Panagiotakos, Demosthenes B. ;

Paragh, Gyorgy ;

Paulweber, Bernhard ;

Pella, Daniel ;

Pitsavos, Christos ;

Reiner, Zeljko ;

Rosano, Giuseppe M. C. ;

Rosenson, Robert S. ;

Rysz, Jacek ;

Sahebkar, Amirhossein ;

Serban, Maria-Corina ;

Vinereanu, Dragos ;

Vrablik, Michal ;

Watts, Gerald F. ;

Wong, Nathan D. ;

Rizzo, Manfredi .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (01) :96-118

[9] PHARMACOKINETIC STUDIES ON IDB-1016, A SILYBIN-PHOSPHATIDYLCHOLINE COMPLEX, IN HEALTHY-HUMAN SUBJECTS [J].

BARZAGHI, N ;

CREMA, F ;

GATTI, G ;

PIFFERI, G ;

PERUCCA, E .

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1990, 15 (04) :333-338

[10] Berberine decreases PCSK9 expression in HepG2 cells [J].

Cameron, Jamie ;

Ranheim, Trine ;

Kulseth, Mari Ann ;

Leren, Trond P. ;

Berge, Knut Erik .

ATHEROSCLEROSIS, 2008, 201 (02) :266-273

← 1 2 3 4 5 6 7 8 9 10 →